Antimalarial drugs could provide hope for Parkinson’s treatment

Written by Alice Weatherston

Scientists based at Nanyang Technological University (Singapore), McLean Hospital (MA, USA) and Harvard Medical School (MA, USA) have recently published data in the Proceedings of the National Academy of Sciences of the United States of America online, indicating that two antimalarial drugs may potentially provide an option for the effective treatment of Parkinson’s disease. The team investigated the role of the protein Nurr1, which has previously been identified as a promising target for Parkinson’s disease. Nurr1 was identified as being instrumental in maintaining the brain’s ability to generate dopamine neurons and consequently prevent progressive loss of movement in rats exhibiting...

To view this content, please register now for access

It's completely free